Most Recent
The company that operates the Newmarch House nursing home in Sydney is facing a possible class action after a coronavirus outbreak at the facility resulted in the deaths of 19 residents.
Shine Lawyers has been given the go ahead to use two reports produced in three settled PFAS class actions as evidence in its latest case over the Defence Department's firefighting foam, with a judge saying any implied undertaking not to re-use the material lost force when the information became public.
Legislation passed by Victoria state lawmakers lifting the ban on contingency fees in class actions will not lead to US-style litigation entrepreneurialism, but it may also not have the desired effect of encouraging smaller and more risky claims, experts told Lawyerly.
Shine Lawyers and barrister David Turner have once again dodged a negligence lawsuit over advice given about a $630,000 contractual dispute, with an appeals court upholding an earlier decision dismissing a bid to join the two parties.
The judge overseeing three class actions against the Commonwealth over its use of allegedly toxic firefighting foam, which have settled for $212.5 million, said backing by a litigation funder led to a better outcome for group members, who would otherwise have been in the disadvantaged position of "supplicants requesting compensation".
A judge has given his blessing to a landmark $212.5 million settlement of three class actions over the use of allegedly toxic firefighting foam at government military bases despite a “large number” of objections.
The settlement of three class actions brought against the Commonwealth of Australia over its alleged use of toxic firefighting foam on government military bases is facing an unusually high number of objections, pushing an approval hearing into a second day as dissenters voice their concerns in court.
Johnson & Johnson subsidiary Ethicon has been hit with an indemnity costs order for "unreasonable conduct" after its loss in last year’s pelvic mesh class action ruling, which found that the pharmaceutical giant did not adequately warn of the risks of the implants.
Eight months after defeating a case brought by the prudential regulator alleging breaches of superannuation laws, wealth manager IOOF has escaped a class action without paying a cent to shareholders.
Medical device giant Johnson & Johnson has confirmed it will not seek the recusal of a Federal Court judge from a panel overseeing its pelvic mesh class action appeal, despite earlier raising concerns that he had seen privileged settlement communications.